A Randomized Controlled Trail on the Efficacy of Topical Olopatadine Hydrochloride 0.1% and Ketotifen Fumarate 0.025% for the Relief of Symptoms of Vernal Keratoconjunctivitis. mfm 2024, 31 (8).